UAE approves ImmunityBio's Anktiva for bladder and lung cancer
Go back to UAE approves ImmunityBio's Anktiva for bladder and lung cancer| (NASDAQ: IBRX) | Delayed: 8.08 -0.11 (1.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.19 | 52 Week High | $ | |||
| Open | $8.08 | 52 Week Low | $ | |||
| Day High | $8.24 | P/E | N/A | |||
| Day Low | $8.01 | EPS | $ | |||
| Volume | 4,330,220 | |||||

